Medtronic announced a partnership with Methinks AI, a radiological triage and notification system provider, to enhance stroke treatment across Central and Eastern Europe, Africa, Türkiye and Middle East, supporting its Neurovascular business. Financial terms of the partnership were not disclosed.
Methinks AI solutions, which has already been validated in hospitals across Europe and the U.S., stands out for its ability to detect over 80% of large vessel occlusions using only non-contrast CT imaging. This capability ensures faster assessment, even in settings with limited access to advanced imaging technologies, reducing critical delays in treatment. Furthermore, Methinks AI has partnered with Microsoft to enhance the scalability and accessibility of this technology.
By integrating Methinks AI with Medtronic stroke treatment portfolio, the partnership will streamline the connectivity between stroke centers and regional hospitals in the region, enabling seamless patient triage and care coordination. The software capability to assess strokes directly from a non-contrast CT scan will empower healthcare providers with timely decision-making tools.
The integration of AI-driven stroke assessment with Medtronic Neurovascular products is expected to accelerate therapy adoption, bringing stroke treatment to a new level of efficiency.
